Atlas Trials

Glucose Transporter Type 1 Deficiency Syndrome

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glucose Transporter Type 1 Deficiency Syndrome

RecordFirmDate
Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease (NCT05085704)Weill Medical College of Cornell University2022-05-03
Evaluation of Ketoflo (NCT04399954)Vitaflo International, Ltd2020-02-24
Early Check: Expanded Screening in Newborns (NCT03655223)RTI International2018-10-15
Evaluation of Krio in Children and Adults With Epilepsy (NCT03202108)Vitaflo International, Ltd2018-05-11
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) (NCT03181399)University of Texas Southwestern Medical Center2018-04-18
Treatment Development of Triheptanoin (G1D) (NCT03041363)Juan Pascual2017-03-29
Evaluation of Keyo in Children With Epilepsy (NCT02915211)Vitaflo International, Ltd2016-04-01
Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) (NCT02021526)Juan Pascual2015-12-01
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome (NCT02000960)University of British Columbia2014-04-01
The Glucose Transporter Type I Deficiency (G1D) Registry (NCT02013583)University of Texas Southwestern Medical Center2013-12-01
Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) (NCT02018315)Juan Pascual2012-01-01
Post Study Continuation of C7 for G1D (NCT02018302)Juan Pascual

Track Glucose Transporter Type 1 Deficiency Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.